Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.58 USD | -1.79% | -4.66% | -16.93% |
05:12pm | Bristol Myers: national schizophrenia campaign | CF |
02:34pm | Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.93% | 87.9B | |
+37.93% | 705B | |
+32.82% | 583B | |
-3.67% | 364B | |
+20.19% | 332B | |
+4.94% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.75% | 169B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Redburn Downgrades Bristol-Myers Squibb to Neutral From Buy, Adjusts Price Target to $54 From $77